Neuro-Radiosurgery & Consultancy
0768.702.927 · rovalta.com · 26/09/2026
Neuro-Radiosurgery & Consultancy
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBONeuro-Radiosurgery & Consultancy is a Private limited company incorporated in 2021. Its registered office is in Schoten.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0768.702.927
- Incorporation
- 25/05/2021
- Legal form
- Private limited company
- Registered office
- Wouwersdreef 23
2900 Schoten · FlandreSee on map - Contributed capital
- 1 000,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 112,6 k € | +2.9% | 109,5 k € | -31.4% | 159,6 k € | +81.9% | 87,7 k € |
| EBITDA | 112,6 k € | +3.0% | 109,3 k € | -31.5% | 159,5 k € | +81.8% | 87,7 k € |
| Operating result | 87,4 k € | +3.9% | 84,1 k € | -38.6% | 137,1 k € | +89.3% | 72,4 k € |
| Net result | 63,5 k € | +5.2% | 60,4 k € | -41.2% | 102,8 k € | +86.0% | 55,2 k € |
| Balance sheet | |||||||
| Equity | 282,9 k € | +29.0% | 219,4 k € | +38.0% | 159 k € | +183% | 56,2 k € |
| Total assets | 438 k € | -24.3% | 578,2 k € | +22.7% | 471,1 k € | +27.7% | 369 k € |
| Cash | 64,8 k € | +50.5% | 43 k € | -24.6% | 57,1 k € | -24.9% | 76 k € |
| Debts | 144,4 k € | -58.6% | 348,7 k € | +13.4% | 307,5 k € | +0.2% | 306,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
Other companies at this address
Wouwersdreef 23 2900 Schoten| Company | CBE no. |
|---|---|
DOKTER COLPAERT CECILE● Active | 0879.747.042 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 25/05/2021 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 8 months |
| Filing date | 29/09/2025 | 09/07/2025 | 13/12/2023 | 10/02/2023 |
| General meeting | 18/09/2025 | 10/06/2025 | 02/11/2023 | 19/01/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other27/05/2021RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202463,5 k €↑
- 2023Annual accounts 202360,4 k €↓
- 2022Annual accounts 2022102,8 k €↑
- 2021Annual accounts 202155,2 k €
- 25/05/2021IncorporationPrivate limited company